Integrating endobronchial ultrasound bronchoscopy with molecular testing of immunotherapy biomarkers in non-small cell lung cancer

Immunotherapy has transformed treatment of advanced non-small-cell lung cancer (NSCLC) patients leading to remarkable long-term survival benefit. However, only about 20% of advanced NSCLC patients typically respond to immune checkpoint inhibitors (ICIs) that target the PD-1/PD-L1 pathway. The only v...

Descripción completa

Detalles Bibliográficos
Autores principales: Bozinovski, Steven, Vannitamby, Amanda, Rangamuwa, Kanishka, Aujla, Savreet, Wang, Hao, Aloe, Christian, Irving, Louis, Leong, Tracy T., Steinfort, Daniel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article on Lung Cancer and The Immune System
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264344/
https://www.ncbi.nlm.nih.gov/pubmed/34295677
http://dx.doi.org/10.21037/tlcr-20-781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264344/
https://www.ncbi.nlm.nih.gov/pubmed/34295677
http://dx.doi.org/10.21037/tlcr-20-781

Ejemplares similares